PURPOSE We aimed to investigate the safety and effectiveness of intracranial stenting in a
population with severe (≥ 70%) symptomatic intracranial internal carotid artery (ICA) …

Background The optimal treatment for intracranial artery stenosis (ICAS) has not been
established. We retrospectively examined the initial and long-term outcomes associated with …

Purpose The use of drug-eluting stent (DES) to treat intracranial stenosis has shown short-
term success. However, there are no reports regarding the long-term results of DES. We …

Stroke in Intracranial Stenosis (SAMMPRIS) trial were published, 1 commentaries that were
critical of the trial or that attempted to explain the poor outcome of patients treated with …

BACKGROUND AND PURPOSE: Different types of symptomatic intracranial stenosis may
respond differently to interventional therapy. We investigated symptomatic and …

Atherosclerotic disease of the major intracranial arteries is a frequent cause of stroke. In
addition, many patients who have symptomatic intracranial stenosis are at very high risk for …

OBJECTIVE: To report the 1-month and intermediate-term results of treatment of
symptomatic intracranial stenosis using drug-eluting stents. BACKGROUND: Patients with …

Background. The high rate of periprocedural complications for the endovascular stent
procedure in the Stenting Versus Aggressive Medical Management Therapy for Intracranial …

Background Randomized clinical trials have failed to prove that the safety and efficacy of
endovascular treatment for symptomatic intracranial atherosclerotic disease (ICAD) is better …

Background and Purpose—Stenting is increasingly used as an adjunct to medical therapy in
symptomatic intracranial stenoses. High periprocedural adverse event rates are one of the …